Medicare Enrolled
Dr. Gerard Abreo, MD
Cardiovascular Disease · Webster, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Abreo from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Abreo?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Abreo
Dr. Gerard Abreo is a cardiovascular disease specialist in Webster, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Abreo performed 4,054 Medicare services across 2,574 unique beneficiaries.
Between the years covered by Open Payments, Dr. Abreo received a total of $12,089 from 59 pharmaceutical and/or device companies across 641 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Abreo is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 24% volume in TX
$12,089 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,054
Medicare services
Top 24% in TX for cardiovascular disease
2,574
Unique beneficiaries
$67
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~213 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,102 | $88 | $315 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
874 | $63 | $219 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
691 | $10 | $49 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
195 | $149 | $651 |
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
138 | $6 | $26 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
109 | $98 | $403 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
105 | $114 | $479 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
88 | $50 | $212 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
80 | $45 | $145 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
74 | $349 | $1,561 |
| Technetium Tc-99m tetrofosmin diagnostic injection A diagnostic injection of Technetium Tc-99m tetrofosmin used for imaging studies. |
73 | $60 | $593 |
| Pacemaker programming, dual lead system Adjustment and configuration of a dual-lead pacemaker device to ensure proper operation and settings. |
66 | $58 | $179 |
| External EKG monitoring, 8-15 days Continuous external electrocardiogram recording and review over a period of 8 to 15 days to monitor heart rhythm. |
63 | $18 | $75 |
| Continuous external EKG monitoring, 8-15 days This procedure involves recording heart rhythm continuously using an external EKG device over a period of 8 to 15 days. |
62 | $8 | $35 |
| Prothrombin time test (blood clotting) A laboratory test that measures how long it takes for blood to clot. This procedure evaluates the body's coagulation process. |
61 | $4 | $94 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
52 | $132 | $586 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
45 | $15 | $67 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
40 | $8 | $85 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
29 | $151 | $561 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while an electrocardiogram is monitored under physician supervision. |
25 | $16 | $66 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram, with physician review of the results. |
25 | $11 | $74 |
| Remote pacemaker/defibrillator monitoring, 90 days Remote evaluation of a pacemaker or implantable defibrillator system within 90 days of the last check. |
18 | $18 | $74 |
| Ultrasound of leg arteries or grafts An imaging test that uses sound waves to create pictures of the blood vessels in the legs or any surgical grafts present. |
15 | $195 | $669 |
| Remote pacemaker monitoring, 90 days Remote assessment of a pacemaker system, including single, dual, multiple lead, or leadless devices, performed up to 90 days apart. |
12 | $24 | $99 |
| Follow-up heart ultrasound An ultrasound of the heart performed to monitor or reassess a previously identified condition or treatment progress. |
12 | $20 | $332 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
7.2% high complexity
10.4% medium
82.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$12,089
Total received (2018-2024)
Avg $1,727/year across 7 years
Top 28% in TX for cardiovascular disease
59
Companies
641
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,089 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,240
2023
$1,789
2022
$1,947
2021
$1,361
2020
$1,166
2019
$1,644
2018
$1,942
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Janssen Pharmaceuticals, Inc
$1,149
Novartis Pharmaceuticals Corporation
$1,093
Amgen Inc.
$882
SANOFI-AVENTIS U.S. LLC
$763
Lundbeck LLC
$665
Amarin Pharma Inc.
$657
Endologix LLC
$529
Boehringer Ingelheim Pharmaceuticals, Inc.
$506
PFIZER INC.
$504
Impulse Dynamics (USA) Inc.
$503
E.R. Squibb & Sons, L.L.C.
$474
Merck Sharp & Dohme LLC
$463
Esperion Therapeutics, Inc.
$370
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$342
Actelion Pharmaceuticals US, Inc.
$338
Boston Scientific Corporation
$274
Tactile Systems Technology Inc
$194
Abbott Laboratories
$186
Gilead Sciences, Inc.
$176
ARBOR PHARMACEUTICALS, INC.
$163
AstraZeneca Pharmaceuticals LP
$154
Bayer HealthCare Pharmaceuticals Inc.
$135
Otsuka America Pharmaceutical, Inc.
$120
BOSTON SCIENTIFIC CORPORATION
$117
Regeneron Healthcare Solutions, Inc.
$99
Lexicon Pharmaceuticals, Inc.
$99
Novo Nordisk Inc
$97
iRhythm Technologies, Inc.
$73
ViiV Healthcare Company
$73
Astellas Pharma US Inc
$69
Azurity Pharmaceuticals, Inc.
$65
ARALEZ PHARMACEUTICALS US INC.
$65
Chiesi USA, Inc.
$60
CVRx, Inc.
$59
Edwards Lifesciences Corporation
$50
Baxter Healthcare
$50
Arbor Pharmaceuticals, Inc.
$39
Allergan, Inc.
$38
ABIOMED
$35
Medtronic Vascular, Inc.
$28
ZOLL Circulation Inc
$26
AGEPHA Pharma FZ LLC
$25
AbbVie Inc.
$24
Lantheus Medical Imaging, Inc.
$22
Paratek Pharmaceuticals, Inc.
$21
Covidien LP
$19
Aytu BioScience, Inc
$19
Kiniksa Pharmaceuticals International, plc
$18
Medtronic, Inc.
$17
Janssen Biotech, Inc.
$17
Kiniksa Pharmaceuticals, Ltd.
$16
ABBVIE INC.
$16
Noden Pharma USA Inc
$16
Shionogi Inc
$14
Kestra Medical Technology Services, Inc.
$13
VYERA PHARMACEUTICALS, LLC
$13
Merck Sharp & Dohme Corporation
$12
Kowa Pharmaceuticals America, Inc.
$11
Melinta Therapeutics, LLC
$11
Top 3 companies account for 25.8% of total payments
Associated products mentioned in payments ›
AVYCAZ · Alto Abdominal Stent Graft System · Arcalyst · Assure WCD · Assurity Pacemaker · BELSOMRA · BRILINTA · BYDUREON · Barostim Neo System · Bidil · CAMZYOS · CARDIOMEMS · CHANTIX · CRESEMBA · Confirm Rx · Corlanor · DALVANCE · DEFINITY · DOVATO · Daraprim · EDARBI · EDARBYCLOR · EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) · ELIQUIS · ENTRESTO · Edarbi · Edarbyclor · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · FARXIGA · FLEXITOUCH · Fetroja · Flexitouch Plus · Hillrom - Cardiac Ambulatory Monitor · Hillrom - Carnation Ambulatory Monitor · INVOKANA · Impella · Inpefa · JARDIANCE · KENGREAL · LATITUDE · LEQVIO · LEXISCAN · LODOCO · LUX DX · LifeVest · Livalo · MULTAQ · MitraClip System · NEXLETOL · NEXLIZET · NORTHERA · NUZYRA · Natesto · OPSUMIT · OPTIMIZER · Optimizer · Ozempic · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · RHYTHMIA · Ranexa · Repatha · Reveal LINQ · SAMSCA · Symtuza · TEKTURNA · Temperature Management System · TruClear · VENASEAL · VERQUVO · VIGILANT · Vabomere · Vascepa · Verquvo · WATCHMAN · WATCHMAN Access System · WATCHMAN FLX · Wegovy · XARELTO · ZIO XT Patch · ZONTIVITY
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $298 per 100 Medicare services performed
Geographic Context
Cardiologists within 10 mi
253
Per 100K population
5.3
County median income
$73,104
Nearest hospital
HCA HOUSTON HEALTHCARE CLEAR LAKE
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Abreo is a clinical cardiology specialist, with above-average Medicare volume (top 24% in TX), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Abreo experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Abreo performed 1,102 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Abreo receive payments from pharmaceutical companies?
Yes. Dr. Abreo received a total of $12,089 from 59 companies across 641 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Abreo's costs compare to other cardiologists in Webster?
Dr. Abreo's average Medicare payment per service is $67. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Abreo) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Webster
Browse cardiologists in Webster ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in TX
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in TX
Which TX cardiologists receive the most from drug and device companies.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology